Top Markets
#1 bitcastle Token bitcastle Token +150.75%
#2 MowCat MowCat +86.64%
#3 MarsCoin MarsCoin +56.26%
#4 Palladium Network Palladium Network +53.30%
#5 Siren Siren +29.58%
#6 Bedrock Bedrock +25.17%
#7 Useless Coin Useless Coin +24.14%
#8 Pons Pons +19.31%
#9 ICON ICON +18.24%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
Coin of the day
bitcastle Token bitcastle Token
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
KemPharm, Inc. KemPharm, Inc.

KemPharm, Inc.

KMPH
Classement en actions #18400
KemPharm, Inc. operates as a specialized pharmaceutical firm focused on... KemPharm, Inc. operates as a specialized pharmaceutical firm focused on discovering and advancing proprietary prodrugs to tackle serious medical conditions across the United States. The company employs its innovative Ligand Activated Therapy (LAT) platform to create improved prodrug versions of medications already approved by the FDA, and also to develop prodrugs from existing compounds for potential applications in new disease indications. Its pipeline of investigational prodrugs strategically targets high-need areas such as attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) disorders, including idiopathic hypersomnia (IH). KP1077, KemPharm's leading experimental compound, is a prodrug of d-methylphenidate, known as serdexmethylphnidate, and is currently in Phase II clinical trials for the treatment of IH and narcolepsy. Additionally, the company is advancing KP879, a prodrug candidate designed to treat stimulant use disorder, which is undergoing Phase I clinical evaluation. KemPharm has also obtained FDA approval for AZSTARYS, a new once-daily ADHD treatment for patients aged six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company holds collaboration and license agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Founded in 2006, KemPharm, Inc. is headquartered in Celebration, Florida.
Prix de l'action
$5.81
Dernière synchronisation: 2023-02-28
Capitalisation boursière
$200.14M
Changement (1 jour)
-0.34%
Changement (1 an)
0.00%
Pays
US
Échange KemPharm, Inc. (KMPH)

Catégorie

Healthcare
Nombre d'actions en circulation pour KemPharm, Inc. (KMPH)
Nombre d'actions en circulation au September 2026: 0
Selon les derniers rapports financiers et le cours de l'action de KemPharm, Inc., le nombre actuel d'actions en circulation est de 0. À la fin de September 2026, l'entreprise avait 0 actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de KemPharm, Inc. (KMPH) de 2026 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
Pas assez de données pour les dates fournies.
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH